Moonage Media Review: Viewbix (VBIX) Targets Israel's Multi-Disciplinary Quantum Hub in Strategic Acquisition Move Toward the Quantum Future
MWN-AI** Summary
Viewbix Inc. (NASDAQ: VBIX), an advanced technologies company, is making significant strides in the quantum technology sector with its strategic acquisition of Quantum X Labs in Israel. This acquisition, signed in mid-December 2025, confirms Viewbix's commitment to advancing its capabilities in quantum innovation. The agreement allows Viewbix to acquire between 85% to 100% of Quantum X Labs, a hub of multi-disciplinary quantum research.
The acquisition is set to close within 90 days subject to regulatory approvals and customary conditions. Recent developments, including majority stockholder consent and SEC filings, demonstrate strong support for the move. The acquisition encompasses Quantum X Labs’ diverse portfolio, which includes patented technologies in areas such as quantum gyroscopy, error correction in quantum computing, and applications in biomedical research.
Quantum X Labs boasts a robust ecosystem of scientists and engineers derived from Israel’s top academic institutions, enabling rapid development of practical quantum applications. Notable projects within the Labs include Quantum Gyro for enhanced navigation in GPS-denied environments and Cliniquantum, which aims to revolutionize drug discovery processes.
By integrating Quantum X Labs into its structure, Viewbix aims to tap into the vast potential of near-term Total Addressable Markets (TAMs) linked to navigation, precision timing, and security solutions derived from quantum technology. This move aligns with global efforts to harness quantum advancements, underlined by Israel’s strong reputation in technological innovation.
Overall, Viewbix's acquisition underscores its strategy to position itself as a key player in the burgeoning quantum technology landscape. However, as with all investments, stakeholders should approach with due diligence and awareness of inherent risks associated with new technologies.
MWN-AI** Analysis
Viewbix Inc. (NASDAQ: VBIX) is making significant strides in the quantum technology arena with its recent acquisition of Israel's Quantum X Labs, which presents a unique investment opportunity. This strategic move enhances VBIX’s position within a sector projected to see tremendous growth as quantum technologies mature.
The acquisition targets key applications in navigation, data security, and biomedical research, promising a robust addressable market. Businesses harnessing quantum computing will likely experience a transformative impact, particularly in complex systems, defense, and healthcare.
Investors should take note of the strategic importance of this acquisition. The recent endorsements from stockholders and regulatory filings indicate robust institutional support, positioning VBIX for a successful transition post-acquisition. The backing of Israel's prestigious academic institutions, including Hebrew University and Tel Aviv University, underscores the innovative potential of Quantum X Labs. Companies like Quantum Gyro and Quantum Transportation are at the forefront of developing technologies that could redefine operational standards across multiple industries.
Prospective investors should consider the potential revenue streams stemming from Quantum X Labs’ diverse projects. The focus on quantum error correction and clinical advancements presents invaluable opportunities in emerging sectors. Furthermore, partnerships, such as that with Rail Vision Ltd. on quantum computing, provide a tactical advantage that could accelerate the integration of these technologies into mainstream applications.
While the quantum technology domain is inherently risky, the ability of Viewbix to navigate these challenges, complemented by their financial maneuvers (including the recent private placement funding), could yield significant returns. However, prudent investors must remain cautious and conduct thorough due diligence, as the landscape of quantum technology is still evolving with unpredictable variables.
In summary, Viewbix’s strategic acquisition places it at a pivotal point in the burgeoning quantum technology market, making it an attractive prospect for investors willing to embrace the associated risks.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
HONG KONG, Feb. 23, 2026 /PRNewswire/ -- Viewbix Inc. (NASDAQ: VBIX), an advanced technologies company, in mid-December 2025, signed a definitive agreement to acquire 85–100% of Israel's Quantum X Labs.
Recent milestones that have been achieved include:
- Majority stockholder written consent secured January 5, 2026.
- Definitive Schedule 14C filed with the SEC January 15, 2026.
- Private placement financing amended early January (800k units at ~$1.75, ~$1.4M gross + up to $1.68M warrant kicker).
Completion of the acquisition and the private placement is expected to occur within 90 calendar days of the date of the definitive agreement, which remains subject to final due diligence, regulatory approvals and customary closing conditions..
But the real fuel is what's happening inside Quantum X Labs' portfolio companies:
- Quantum Gyro: Developing quantum gyroscope technology that is reliable for GPS-denied environments, essential for defense, autonomous vehicles, and remote operations.
- Quantum Transportation: Addressing scalability issues in quantum computing with patented solution (QECC) that reduce quantum computational noises. The Company already started working with Rail Vision Ltd. (Nasdaq: RVSN), which acquired 51% of Quantum Transportation in January 2026, on harnessing quantum computing and reducing errors in big data analysis and major transportation platforms.
- Cliniquantum: Focused on clinical and biomedical research, including a recent provisional patent for quantum-enhanced Markov Chain Monte Carlo methods that could revolutionize drug discovery by uncovering hidden biological structures in trial data.
- Quantum Aton Accuracy: Leveraging quantum principles for unprecedented precision in timing and synchronization applications.
- QuantumQ Security: Protecting data, communications, and critical infrastructure against emerging threats.
- Nuclear Quantum- Working on the development of breakthrough applications where quantum computing eliminates the fundamentals bottlenecks in reactor simulation, safety verification and materials science.
Quantum X Labs offers exposure to quantum's biggest near-term TAMs: navigation, precision timing, security, error correction, nuclear simulation. Israel's elite university ecosystem (Hebrew U, TAU, Technion, Weizmann) supplies the talent edge, and the Denmark quantum conference showcase last fall already introduced them to the market.
Founded on the vision that quantum progress thrives through interdisciplinary convergence, Quantum X Labs has built a unique ecosystem uniting top-tier talent and cutting-edge research. Drawing from Israel's renowned academic powerhouses- including the Hebrew University of Jerusalem, Tel Aviv University, the Technion, and the Weizmann Institute- Quantum X Labs employs a multidisciplinary team of scientists, engineers, and researchers. This blend of theoretical expertise and practical engineering has enabled rapid translation of ideas into deployable technologies, positioning Quantum X Labs as a player in Israel's quantum sector.
Viewbix recently signed a definitive agreement to acquire up to 100% (and not less than 85%) of Quantum X Labs (the "Acquisition"), encompassing its expanding patent portfolio, including prior IP in quantum error correction. The acquisition is expected to close within 90 days of the date of execution of the definitive agreement, which was December 15, 2025, subject to final due diligence, regulatory approvals, and customary closing conditions. On January 5, 2026, Viewbix announced that it had received the requisite stockholder approval via written consent of the majority of its stockholders (the "Stockholder Consent") and on January 15, 2026, Viewbix filed a definitive information statement on Schedule 14C with the Securities and Exchange Commission. Pursuant to Delaware Law, the actions to be taken pursuant to the Stockholder Consent shall be effective on the 20th day after the definitive information statement on Schedule 14C is mailed or furnished to Viewbix's stockholders.
Paid Promotional Disclosure
This press release constitutes a paid promotional communication. Viewbix has engaged a third-party service provider to provide investor awareness and promotional services, including the dissemination of this press release, and has paid a fee for such services. Viewbix exercises editorial control over the content of this press release but does not control how, when, or to whom the information is distributed by such third party.
This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of Viewbix. Investing in Viewbix's securities involves significant risks, and readers are encouraged to review Viewbix's filings with the U.S. Securities and Exchange Commission available at www.sec.gov before making any investment decision.
Moonage Media Disclaimer
This article was produced by Moonage Media, a brand / division of MR Solutions Limited (Hong Kong), and is provided for general informational and promotional purposes only. The content does not constitute investment advice, financial advice, medical advice, or a recommendation to buy, sell, or hold any securities, nor does it constitute an offer or solicitation in any jurisdiction.
Moonage Media is not a registered broker-dealer, investment adviser, securities analyst, or medical professional. The information presented is based on publicly available sources and statements believed to be reliable at the time of publication; however, Moonage Media makes no representations or warranties as to the accuracy or completeness of the information and has not independently verified all data referenced.
Certain content published by Moonage Media may be sponsored or compensated by the company discussed or its affiliates, which may create a potential conflict of interest. Readers are encouraged to conduct their own independent research and consult qualified financial, legal, medical, or other professional advisers before making any investment or health-related decisions.
Forward-looking statements referenced in this article are subject to risks and uncertainties, and actual results may differ materially. Past performance is not indicative of future results.
For full disclosures, risk factors, and forward-looking statements, please visit:
https://moonage.media/disclaimer/
Contact:
Moonage Media
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, forward-looking statements in this press release include the timing and completion of the acquisition and the private placement, the receipt of regulatory approvals, the satisfaction of closing conditions related to the acquisition and positioning Quantum X Labs as a player in Israel's quantum sector. Because such statements deal with future events and are based on Viewbix's current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix is not responsible for the contents of third-party websites.
SOURCE Moonage Media
FAQ**
How does Viewbix Inc. (VBIX) plan to leverage its acquisition of Quantum X Labs to enhance its competitive position within the rapidly evolving quantum technology sector?
What specific milestones can investors expect from Viewbix Inc. (VBIX) following the acquisition of Quantum X Labs in terms of product development and revenue growth?
Can Viewbix Inc. (VBIX) provide more details on the regulatory approvals and customary closing conditions that may impact the completion of the Quantum X Labs acquisition?
What risks and uncertainties should investors be aware of concerning the long-term return on investment from Viewbix Inc. (VBIX) following its strategic acquisition of Quantum X Labs?
**MWN-AI FAQ is based on asking OpenAI questions about ViewBix Inc (OTC: VBIX).
NASDAQ: VBIX
VBIX Trading
27.29% G/L:
$7 Last:
24,504 Volume:
$5.09 Open:
